FACEPHI BIOMETRIA SA (ALPHI.PA) Stock Fundamental Analysis

EPA:ALPHI • ES0105029005

2.42 EUR
+0.01 (+0.41%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

ALPHI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 122 industry peers in the Software industry. ALPHI may be in some trouble as it scores bad on both profitability and health. ALPHI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ALPHI had negative earnings in the past year.
  • In the past year ALPHI had a positive cash flow from operations.
  • ALPHI had negative earnings in 4 of the past 5 years.
  • In multiple years ALPHI reported negative operating cash flow during the last 5 years.
ALPHI.PA Yearly Net Income VS EBIT VS OCF VS FCFALPHI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

  • The Return On Assets of ALPHI (-19.65%) is worse than 82.79% of its industry peers.
  • ALPHI has a worse Return On Equity (-46.24%) than 80.33% of its industry peers.
Industry RankSector Rank
ROA -19.65%
ROE -46.24%
ROIC N/A
ROA(3y)-7.9%
ROA(5y)-7.67%
ROE(3y)-20.34%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
ALPHI.PA Yearly ROA, ROE, ROICALPHI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • ALPHI has a worse Gross Margin (53.83%) than 68.85% of its industry peers.
  • ALPHI's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALPHI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.32%
GM growth 5Y-11.24%
ALPHI.PA Yearly Profit, Operating, Gross MarginsALPHI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • ALPHI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALPHI has been increased compared to 1 year ago.
  • The number of shares outstanding for ALPHI has been increased compared to 5 years ago.
  • The debt/assets ratio for ALPHI has been reduced compared to a year ago.
ALPHI.PA Yearly Shares OutstandingALPHI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ALPHI.PA Yearly Total Debt VS Total AssetsALPHI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of 1.34, we must say that ALPHI is in the distress zone and has some risk of bankruptcy.
  • ALPHI's Altman-Z score of 1.34 is on the low side compared to the rest of the industry. ALPHI is outperformed by 66.39% of its industry peers.
  • ALPHI has a debt to FCF ratio of 5.75. This is a neutral value as ALPHI would need 5.75 years to pay back of all of its debts.
  • ALPHI has a Debt to FCF ratio (5.75) which is in line with its industry peers.
  • ALPHI has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.04, ALPHI belongs to the best of the industry, outperforming 80.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 5.75
Altman-Z 1.34
ROIC/WACCN/A
WACC9.74%
ALPHI.PA Yearly LT Debt VS Equity VS FCFALPHI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

  • ALPHI has a Current Ratio of 1.00. This is a normal value and indicates that ALPHI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ALPHI (1.00) is worse than 67.21% of its industry peers.
  • A Quick Ratio of 1.00 indicates that ALPHI may have some problems paying its short term obligations.
  • With a Quick ratio value of 1.00, ALPHI is not doing good in the industry: 67.21% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
ALPHI.PA Yearly Current Assets VS Current LiabilitesALPHI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ALPHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.54%.
  • ALPHI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.11%.
  • The Revenue has been growing by 28.76% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y30.13%
Revenue growth 5Y28.76%
Sales Q2Q%8.33%

3.2 Future

  • ALPHI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.14% yearly.
  • Based on estimates for the next years, ALPHI will show a quite strong growth in Revenue. The Revenue will grow by 19.34% on average per year.
EPS Next Y104%
EPS Next 2Y50%
EPS Next 3Y36.8%
EPS Next 5Y29.14%
Revenue Next Year25.74%
Revenue Next 2Y24.47%
Revenue Next 3Y19.64%
Revenue Next 5Y19.34%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALPHI.PA Yearly Revenue VS EstimatesALPHI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M
ALPHI.PA Yearly EPS VS EstimatesALPHI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • ALPHI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 28.47, which means the current valuation is very expensive for ALPHI.
  • ALPHI's Price/Forward Earnings is on the same level as the industry average.
  • ALPHI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.96.
Industry RankSector Rank
PE N/A
Fwd PE 28.47
ALPHI.PA Price Earnings VS Forward Price EarningsALPHI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALPHI is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALPHI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 39.49
EV/EBITDA 45.08
ALPHI.PA Per share dataALPHI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALPHI's earnings are expected to grow with 36.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50%
EPS Next 3Y36.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALPHI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FACEPHI BIOMETRIA SA

EPA:ALPHI (2/13/2026, 7:00:00 PM)

2.42

+0.01 (+0.41%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-20
Earnings (Next)04-27
Inst Owners27.19%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap62.39M
Revenue(TTM)30.00M
Net Income(TTM)-7.86M
Analysts82.5
Price Target3.4 (40.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.39%
PT rev (3m)9.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.47
P/S 2.08
P/FCF 39.49
P/OCF 8.13
P/B 3.67
P/tB 12.48
EV/EBITDA 45.08
EPS(TTM)-0.29
EYN/A
EPS(NY)0.08
Fwd EY3.51%
FCF(TTM)0.06
FCFY2.53%
OCF(TTM)0.3
OCFY12.29%
SpS1.16
BVpS0.66
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.65%
ROE -46.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.83%
FCFM 5.27%
ROA(3y)-7.9%
ROA(5y)-7.67%
ROE(3y)-20.34%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.32%
GM growth 5Y-11.24%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 5.75
Debt/EBITDA 0.48
Cap/Depr 101.67%
Cap/Sales 20.3%
Interest Coverage N/A
Cash Conversion 485.44%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 1.34
F-Score5
WACC9.74%
ROIC/WACCN/A
Cap/Depr(3y)134.94%
Cap/Depr(5y)175.33%
Cap/Sales(3y)22.27%
Cap/Sales(5y)23.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y104%
EPS Next 2Y50%
EPS Next 3Y36.8%
EPS Next 5Y29.14%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y30.13%
Revenue growth 5Y28.76%
Sales Q2Q%8.33%
Revenue Next Year25.74%
Revenue Next 2Y24.47%
Revenue Next 3Y19.64%
Revenue Next 5Y19.34%
EBIT growth 1Y37.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year168.63%
EBIT Next 3Y52.17%
EBIT Next 5Y44.47%
FCF growth 1Y110.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y164.15%
OCF growth 3YN/A
OCF growth 5YN/A

FACEPHI BIOMETRIA SA / ALPHI.PA FAQ

What is the fundamental rating for ALPHI stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALPHI.PA.


What is the valuation status for ALPHI stock?

ChartMill assigns a valuation rating of 3 / 10 to FACEPHI BIOMETRIA SA (ALPHI.PA). This can be considered as Overvalued.


What is the profitability of ALPHI stock?

FACEPHI BIOMETRIA SA (ALPHI.PA) has a profitability rating of 1 / 10.


What is the financial health of FACEPHI BIOMETRIA SA (ALPHI.PA) stock?

The financial health rating of FACEPHI BIOMETRIA SA (ALPHI.PA) is 3 / 10.